BOLT Shares Outstanding History
Below is a table of the BOLT shares outstanding history going back to 2/5/2021:

Date BOLT Shares Outstanding
2/5/202131.85M
3/26/202136.33M

Also see: BOLT Market Cap History
BOLT YTD Return
BOLT Historical Shares Outstanding:
+107.00% CAGR
BOLT Historical Shares Outstanding: +107.00% CAGR

Mouse over chart for data details
2/5/2021 ...3/26/2021
Bolt Biotherapeutics is a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. Co. develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Co.'s preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. We show 2 historical shares outstanding datapoints in our coverage of BOLT's shares outstanding history.

Understanding the changing numbers of BOLT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BOLT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BOLT by allowing them to research BOLT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for BOLT:
BOLT SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bolt Biotherapeutics (BOLT) is categorized under the Energy sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BP Shares Outstanding History
BPL Shares Outstanding History
BRY Shares Outstanding History
BSM Shares Outstanding History
BTE Shares Outstanding History
BWP Shares Outstanding History
CAPL Shares Outstanding History
CCLP Shares Outstanding History
CDEV Shares Outstanding History
CELP Shares Outstanding History
More Energy companies »

 

BOLT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.